Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibiotic resistance
Research
Shionogi offers $600M for Swiss biotech's antibiotic program
Shionogi and BioVersys will work together to develop new ansamycin candidates for nontuberculous mycobacteria infections.
Darren Incorvaia
Jul 2, 2025 1:00am
Armata links bacteria-killing virus to responses in phase 2
May 19, 2025 8:41am
Newfound compound kills multi-drug-resistant fungi
Mar 19, 2025 12:00pm
VC firm launches biotech aiming to counter antibiotic resistance
Feb 24, 2025 7:15am
New antibiotic kills flesh-eating bacteria in preclinical study
Aug 2, 2024 2:00pm
Lilly, OpenAI team up to tackle antimicrobial resistance
Jun 25, 2024 10:41am
